Now, they’re set to cash in on "turbo cancers."

Pfizer’s head of cancer, expects their new cancer drugs from Seagen could bring in $10 billion a year by 2030.

Why is Pfizer so focused on cancer? Maybe because more and more young people are getting cancer than ever before.

Dr. William Makis, an oncologist, says he’s “never seen anything like this.” He blames the so-called COVID vaccines.

"I've never seen stage four breast cancers presenting in women in their 20s. I've never seen stage four colon cancers presenting in men and women in their 20s [and] 30s. Leukemias that will kill you in a matter of days or even hours after diagnosis," Dr. Makis lamented.

With COVID vax sales plummeting, Pfizer’s stock has dropped 20% in the last year.

Now, they’re all-in on cancer. It’s hard to believe that their new focus is some sort of coincidence.